Title: Investigating the Association Between SARS-CoV-2 Infection, COVID-19 Vaccination, and Autoimmune Diseases in a Pediatric Population
Authors: Freiberg et al. (2025)
Objective:
To assess whether there was a change in the incidence of new-onset autoimmune diseases (AIDs) among children during the COVID-19 pandemic, and whether COVID-19 infection or vaccination was associated with that change.
Data & Methods:
Retrospective study of 493,705 anonymized medical records from Maccabi Healthcare Services (Israel), spanning 2014–2022.
Pediatric patients (ages 1–21) were divided into three cohorts:
Group A: Pre-pandemic (2014–2016)
Group B: Pre-pandemic (2017–2019)
Group C: Pandemic (2020–2022)
Incidence of autoimmune diseases was compared across groups.
A nested case-control analysis assessed associations between COVID-19 infection, vaccination, and autoimmune diagnoses during the pandemic.
Key Findings:
Overall Incidence: Remained stable across all periods (~0.9–1.0%). No significant increase during the pandemic (p = 0.13).
COVID-19 Infection: Not significantly associated with increased risk of autoimmune disease (HR 1.09, p = 0.491).
COVID-19 Vaccination: Associated with a statistically significant increase in risk of developing autoimmune diseases (HR 1.23, p = 0.0033). This represents an absolute risk increase of 0.21%.
Latency: Median time from vaccination to autoimmune diagnosis was ~8.7 months.
Specific Diseases:
Increased during pandemic: Celiac disease, Raynaud’s phenomenon
Decreased during pandemic: Arthritis
Some diseases showed no change.
Limitations:
Potential underreporting of hospital-managed cases like MIS-C.
Possible bias from increased healthcare engagement among vaccinated families.
Study unable to account for all behavioral or diagnostic factors retrospectively.
Conclusion:
While the overall rate of autoimmune diseases in children remained unchanged during the pandemic, a modest but statistically significant association was found between COVID-19 vaccination and increased autoimmune disease diagnoses. The absolute risk remains low, and the study underscores the importance of balancing this risk against the known benefits of vaccination, especially in preventing severe illness like MIS-C.
Recommendation:
Further prospective studies are needed to better understand causality and identify vulnerable subgroups.
Unbiased Summary of the Study:
Title: Investigating the Association Between SARS-CoV-2 Infection, COVID-19 Vaccination, and Autoimmune Diseases in a Pediatric Population
Authors: Freiberg et al. (2025)
Objective: To assess whether there was a change in the incidence of new-onset autoimmune diseases (AIDs) among children during the COVID-19 pandemic, and whether COVID-19 infection or vaccination was associated with that change.
Data & Methods:
Retrospective study of 493,705 anonymized medical records from Maccabi Healthcare Services (Israel), spanning 2014–2022.
Pediatric patients (ages 1–21) were divided into three cohorts:
Group A: Pre-pandemic (2014–2016)
Group B: Pre-pandemic (2017–2019)
Group C: Pandemic (2020–2022)
Incidence of autoimmune diseases was compared across groups.
A nested case-control analysis assessed associations between COVID-19 infection, vaccination, and autoimmune diagnoses during the pandemic.
Key Findings:
Overall Incidence: Remained stable across all periods (~0.9–1.0%). No significant increase during the pandemic (p = 0.13).
COVID-19 Infection: Not significantly associated with increased risk of autoimmune disease (HR 1.09, p = 0.491).
COVID-19 Vaccination: Associated with a statistically significant increase in risk of developing autoimmune diseases (HR 1.23, p = 0.0033). This represents an absolute risk increase of 0.21%.
Latency: Median time from vaccination to autoimmune diagnosis was ~8.7 months.
Specific Diseases:
Increased during pandemic: Celiac disease, Raynaud’s phenomenon
Decreased during pandemic: Arthritis
Some diseases showed no change.
Limitations:
Potential underreporting of hospital-managed cases like MIS-C.
Possible bias from increased healthcare engagement among vaccinated families.
Study unable to account for all behavioral or diagnostic factors retrospectively.
Conclusion: While the overall rate of autoimmune diseases in children remained unchanged during the pandemic, a modest but statistically significant association was found between COVID-19 vaccination and increased autoimmune disease diagnoses. The absolute risk remains low, and the study underscores the importance of balancing this risk against the known benefits of vaccination, especially in preventing severe illness like MIS-C.
Recommendation: Further prospective studies are needed to better understand causality and identify vulnerable subgroups.